To Evaluate The Effectiveness Of Sarapanga Vilvathy Legiyam In The Treatment Of Acid Peptic Disease (Eri gunmam)
Phase 2
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive system
- Registration Number
- CTRI/2023/09/057631
- Lead Sponsor
- ot Applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient with the symptoms of epigastric abdominal pain, Heart burn with or without regurgitation, abdominal bloating, nausea, vomiting, belching, hematemesis (Any 3 or 4)
2.Willing to take endoscopy before and after the trial period.
3.Willing to give blood specimen for the investigation when required.
4.Patient who are willing to sign informed consent form.
Exclusion Criteria
1.k/c/o Diabetes mellitus
2.k/c/o Hypertension
3.k/c/o Cardiac ailments
4.Known Cases of Acute Abdomen (Appendicitis, Pancreatitis, Cholecystitis)
5.k/c/o Hiatus hernia
6.k/c/o Gastric/ Esophageal Carcinoma
7.k/c/o Liver cirrhosis
8.Pregnancy and lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome assessed by comparing the reduction of clinical symptoms before & after treatment by using Gastro-intestinal symptoms rating scale (GSRS). <br/ ><br>Timepoint: 6 months
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the Endoscopic results before & after treatment for 20 percentage of selected patients.Timepoint: 6 months